Floatz logo

Therapeutic Asset Ratings

3,272 results matching 1 filter

91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Atezolizumab
Papillary Renal Cell Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Atezolizumab
Infiltrating Bladder Urothelial Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Atezolizumab
Bladder Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Atezolizumab
Extrahepatic Bile Duct Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Atezolizumab
IDH-Wildtype Glioblastoma
National Cancer Institute (NCI)P2CCC (53)
Atezolizumab
Renal Pelvis/Ureter Urothelial Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Atezolizumab
Bladder Small Cell Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Atezolizumab
Bladder Squamous Cell Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Atezolizumab
Squamous Cell Carcinoma Of Penis
National Cancer Institute (NCI)P2CCC (53)
Atezolizumab
Pure Squamous Carcinoma Of The Urothelial Tract
National Cancer Institute (NCI)P2CCC (53)
Atezolizumab
Distal Biliary Tract Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Atezolizumab
Lung Superior Sulcus Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Atl-Ric
Immune System Disorder
National Cancer Institute (NCI)P2CCC (53)
Atl-Ric
Lymphoproliferative Syndrome
National Cancer Institute (NCI)P2CCC (53)
Atl-Ric
Mature T-Cell And NK-Cell Non-Hodgkin Lymphoma
National Cancer Institute (NCI)P2CCC (53)
Atropine
Cervical Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Atropine
Endometrial Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Atropine
Ovarian Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Axitinib
Renal Cell Carcinoma Associated With Xp11.2 Translocations/TFE3 Gene Fusions
National Cancer Institute (NCI)P2CCC (53)
Azacitidine
Myelodysplastic Syndrome With Excess Blasts-1
National Cancer Institute (NCI)P2CCC (53)
Balstilimab
Renal Cell Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Binimetinib
Lymphoma
National Cancer Institute (NCI)P2CCC (53)
Binimetinib
Urinary Bladder Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Binimetinib
Cervical Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Binimetinib
Endometrial Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Showing 1051 to 1075 of 3,272 assets
PreviousPage 43 of 131Next